• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定一种新型疫苗佐剂,该佐剂能刺激和维持白喉类毒素免疫。

Identification of a novel vaccine adjuvant that stimulates and maintains diphtheria toxoid immunity.

机构信息

Department of Pathology, University of Melbourne, Parkville, Vic., 3010, Australia.

出版信息

Vaccine. 2010 May 14;28(22):3865-73. doi: 10.1016/j.vaccine.2010.02.073. Epub 2010 Mar 1.

DOI:10.1016/j.vaccine.2010.02.073
PMID:20197137
Abstract

Immunomodulation by plant-derived medicines is well-documented with effects on both innate and adaptive immunity. This study reports potent and long-lasting diphtheria toxoid-specific immunity by the botanical medicinal, Rehmannia Six Formula, using an in vivo mouse model of vaccine immunity. A significant vaccine adjuvant effect was observed with an increase in serum anti-diphtheria toxoid total and IgG antibodies following oral administration of Rehmannia Six Formula to mice. This response was antigen-specific and was still detectable six months following botanical medicinal treatment, suggesting that Rehmannia Six Formula could help maintain protective antibody levels in populations where vaccine coverage is low. Rehmannia Six Formula was well-tolerated with no adverse effects on mouse weight or survival observed in this study and suggests a potential role as a novel vaccine adjuvant preparation.

摘要

植物药的免疫调节作用已有充分的文献记载,对先天免疫和适应性免疫都有影响。本研究报告了一种植物药——地黄六方,在体内疫苗免疫的小鼠模型中,具有强大而持久的白喉类毒素特异性免疫作用。通过口服地黄六方,观察到血清抗白喉类毒素总抗体和 IgG 抗体显著增加,具有显著的疫苗佐剂作用。这种反应是抗原特异性的,在植物药治疗六个月后仍能检测到,这表明地黄六方可能有助于维持疫苗覆盖率低的人群中的保护性抗体水平。地黄六方耐受性良好,在本研究中未观察到对小鼠体重或生存的不良影响,提示其可能作为一种新型疫苗佐剂制剂发挥作用。

相似文献

1
Identification of a novel vaccine adjuvant that stimulates and maintains diphtheria toxoid immunity.鉴定一种新型疫苗佐剂,该佐剂能刺激和维持白喉类毒素免疫。
Vaccine. 2010 May 14;28(22):3865-73. doi: 10.1016/j.vaccine.2010.02.073. Epub 2010 Mar 1.
2
Stimulation of tetanus toxoid-specific immune responses by a traditional Chinese herbal medicine.一种传统中药对破伤风类毒素特异性免疫反应的刺激作用。
Vaccine. 2009 Nov 5;27(47):6634-41. doi: 10.1016/j.vaccine.2009.03.051. Epub 2009 Apr 8.
3
The mucosal adjuvanticity of the oligodeoxynucleotides containing a non-methylated CpG motif on BCG and diphtheria toxoid.含非甲基化CpG基序的寡脱氧核苷酸对卡介苗和白喉类毒素的黏膜佐剂性。
Vaccine. 2009 Feb 18;27(8):1166-73. doi: 10.1016/j.vaccine.2008.12.025. Epub 2009 Jan 9.
4
Induction of protective and mucosal immunity against diphtheria by a immune stimulating complex (ISCOMS) based vaccine.基于免疫刺激复合物(ISCOMS)的疫苗诱导对白喉的保护性和黏膜免疫。
Vaccine. 2006 Jun 12;24(24):5201-10. doi: 10.1016/j.vaccine.2006.03.081. Epub 2006 Apr 17.
5
A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity.一种由合成的先天性防御调节肽和CpG寡核苷酸组成的新型疫苗佐剂可连接先天性免疫和适应性免疫。
Vaccine. 2009 Jul 23;27(34):4662-71. doi: 10.1016/j.vaccine.2009.05.094. Epub 2009 Jun 17.
6
Oral vaccination against diphtheria using polyacryl starch microparticles as adjuvant.使用聚丙烯淀粉微粒作为佐剂进行白喉口服疫苗接种。
Vaccine. 2004 Mar 12;22(9-10):1265-74. doi: 10.1016/j.vaccine.2003.09.034.
7
Effect of monophosphoryl lipid A on antibody response to diphtheria toxin and its subunits.单磷酰脂质A对白喉毒素及其亚基抗体反应的影响。
APMIS. 2005 Apr;113(4):256-63. doi: 10.1111/j.1600-0463.2005.apm_03.x.
8
Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency.对因免疫缺陷而接受评估的儿童进行白喉/破伤风再接种后的特异性抗体反应。
Ann Allergy Asthma Immunol. 1997 Aug;79(2):145-50. doi: 10.1016/S1081-1206(10)63101-8.
9
Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.使用新型脂质佐剂进行经皮免疫可预防衣原体性生殖道和呼吸道感染。
Vaccine. 2009 Oct 19;27(44):6217-25. doi: 10.1016/j.vaccine.2009.08.001. Epub 2009 Aug 19.
10
Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.鼻内给药是一种有效的黏膜疫苗递送途径,用于针对A组链球菌M蛋白的自佐剂脂质核心肽。
J Infect Dis. 2006 Aug 1;194(3):316-24. doi: 10.1086/505580. Epub 2006 Jun 30.

引用本文的文献

1
Japanese Kampo medicine ninjin'yoeito synergistically enhances tumor vaccine effects mediated by CD8 T cells.日本汉方医学人参养荣汤可协同增强由CD8 T细胞介导的肿瘤疫苗效应。
Oncol Lett. 2017 May;13(5):3471-3478. doi: 10.3892/ol.2017.5937. Epub 2017 Mar 28.